Birdwatch Note
2024-10-22 21:47:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Les résultats de plusieurs essais randomisés contre placebo, de bonne qualité méthodologique, permettent aujourd’hui d'affirmer l'absence d'efficacité de l’ivermectine, quel que soit la dose utilisée, en prévention ou en traitement du Covid-19. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19
Written by 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848740798554157359
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848843565193142398
- noteId - 1848843565193142398
- participantId -
- noteAuthorParticipantId - 2525A116715768A7CC42C4D4C38E8A47813D758DA9DE7F9DD237BFCE01BDCADB Participant Details
- createdAtMillis - 1729633630451
- tweetId - 1848740798554157359
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Les résultats de plusieurs essais randomisés contre placebo, de bonne qualité méthodologique, permettent aujourd’hui d'affirmer l'absence d'efficacité de l’ivermectine, quel que soit la dose utilisée, en prévention ou en traitement du Covid-19. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19
Note Ratings
| rated at | rated by | |
| 2024-10-22 21:35:55 -0500 | Rating Details | |
| 2024-10-23 01:57:43 -0500 | Rating Details | |
| 2024-10-22 20:47:28 -0500 | Rating Details | |
| 2024-10-23 00:24:24 -0500 | Rating Details | |
| 2024-10-23 03:30:12 -0500 | Rating Details | |
| 2024-10-23 02:46:43 -0500 | Rating Details | |
| 2024-10-23 01:57:53 -0500 | Rating Details | |
| 2024-10-22 22:13:43 -0500 | Rating Details | |
| 2024-10-23 03:33:16 -0500 | Rating Details |